- Home
- NSIT vs SRRK Comparison
NSIT vs SRRK Comparison
Compare NSIT & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSIT
- SRRK
- Stock Information
- Founded
- NSIT 1988
- SRRK 2012
- Country
- NSIT United States
- SRRK United States
- Employees
- NSIT N/A
- SRRK N/A
- Industry
- NSIT EDP Services
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NSIT Technology
- SRRK Health Care
- Exchange
- NSIT Nasdaq
- SRRK Nasdaq
- Market Cap
- NSIT 3.6B
- SRRK 3.0B
- IPO Year
- NSIT 1995
- SRRK 2018
- Fundamental
- Price
- NSIT $110.82
- SRRK $41.81
- Analyst Decision
- NSIT Buy
- SRRK Strong Buy
- Analyst Count
- NSIT 3
- SRRK 9
- Target Price
- NSIT $183.00
- SRRK $45.25
- AVG Volume (30 Days)
- NSIT 374.0K
- SRRK 2.7M
- Earning Date
- NSIT 10-30-2025
- SRRK 11-11-2025
- Dividend Yield
- NSIT N/A
- SRRK N/A
- EPS Growth
- NSIT N/A
- SRRK N/A
- EPS
- NSIT 4.21
- SRRK N/A
- Revenue
- NSIT $8,355,589,000.00
- SRRK N/A
- Revenue This Year
- NSIT $0.34
- SRRK N/A
- Revenue Next Year
- NSIT $4.83
- SRRK $1,996.18
- P/E Ratio
- NSIT $26.28
- SRRK N/A
- Revenue Growth
- NSIT N/A
- SRRK N/A
- 52 Week Low
- NSIT $108.31
- SRRK $22.71
- 52 Week High
- NSIT $225.38
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- NSIT 26.13
- SRRK 65.02
- Support Level
- NSIT $110.54
- SRRK $34.52
- Resistance Level
- NSIT $113.74
- SRRK $41.01
- Average True Range (ATR)
- NSIT 2.88
- SRRK 2.51
- MACD
- NSIT -0.35
- SRRK 0.64
- Stochastic Oscillator
- NSIT 0.00
- SRRK 94.92
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.